These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 18185140)

  • 21. Safety of intravitreal high-dose reinjections of triamcinolone acetonide.
    Jonas JB; Degenring R; Kreissig I; Akkoyun I
    Am J Ophthalmol; 2004 Dec; 138(6):1054-5. PubMed ID: 15629306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraocular pressure elevation after injection of triamcinolone acetonide: a multicenter retrospective case-control study.
    Inatani M; Iwao K; Kawaji T; Hirano Y; Ogura Y; Hirooka K; Shiraga F; Nakanishi Y; Yamamoto H; Negi A; Shimonagano Y; Sakamoto T; Shima C; Matsumura M; Tanihara H
    Am J Ophthalmol; 2008 Apr; 145(4):676-681. PubMed ID: 18243153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early rapid rise in intraocular pressure after intravitreal triamcinolone acetonide injection.
    Singh IP; Ahmad SI; Yeh D; Challa P; Herndon LW; Allingham RR; Lee PP
    Am J Ophthalmol; 2004 Aug; 138(2):286-7. PubMed ID: 15289140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ocular morbidity associated with intravitreal triamcinolone acetonide.
    Konstantopoulos A; Williams CP; Newsom RS; Luff AJ
    Eye (Lond); 2007 Mar; 21(3):317-20. PubMed ID: 16710433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secondary elevated IOP and cataracts after high-dose intravitreal triamcinolone and photodynamic therapy to treat choroidal neovascularization.
    Ruiz-Moreno JM; Montero JA; Amat P; Lugo FL
    J Glaucoma; 2009 Jan; 18(1):69-72. PubMed ID: 19142138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of repeated injection of intravitreal triamcinolone on macular oedema in central retinal vein occlusion.
    Wang L; Song H
    Acta Ophthalmol; 2009 May; 87(3):285-9. PubMed ID: 18507724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Presumed sterile endophthalmitis following intravitreal triamcinolone acetonide injection.
    Moshfeghi DM; Kaiser PK; Bakri SJ; Kaiser RS; Maturi RK; Sears JE; Scott IU; Belmont J; Beer PM; Quiroz-Mercado H; Mieler WF
    Ophthalmic Surg Lasers Imaging; 2005; 36(1):24-9. PubMed ID: 15688968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term effect of intravitreal triamcinolone in the nonproliferative stage of type II idiopathic parafoveal telangiectasia.
    Wu L; Evans T; Arévalo JF; Berrocal MH; Rodríguez FJ; Hsu M; Sánchez JG
    Retina; 2008 Feb; 28(2):314-9. PubMed ID: 18301037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased incidence of sterile endophthalmitis following intravitreal preserved triamcinolone acetonide.
    Jonisch J; Lai JC; Deramo VA; Flug AJ; Fastenberg DM
    Br J Ophthalmol; 2008 Aug; 92(8):1051-4. PubMed ID: 18653598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of intravitreal corticosteroids, evidence-based and otherwise.
    Conti SM; Kertes PJ
    Curr Opin Ophthalmol; 2006 Jun; 17(3):235-44. PubMed ID: 16794435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency and management of raised intraocular pressure following intravitreal triamcinolone acetonide.
    Mahar PS; Memon AS
    J Coll Physicians Surg Pak; 2012 Nov; 22(11):699-702. PubMed ID: 23146849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Refractory severe ocular hypertension after intravitreal triamcinolone acetonide injection.
    Yang CS; Chen MJ; Chou CK; Hsu WM
    Ophthalmologica; 2005; 219(6):413-5. PubMed ID: 16286805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sterile endophthalmitis after intravitreal triamcinolone: a possible association with uveitis.
    Taban M; Singh RP; Chung JY; Lowder CY; Perez VL; Kaiser PK
    Am J Ophthalmol; 2007 Jul; 144(1):50-54. PubMed ID: 17601427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravitreal triamcinolone acetonide injection at the end of vitrectomy for diabetic vitreous hemorrhage: a randomized, clinical trial.
    Faghihi H; Taheri A; Farahvash MS; Esfahani MR; Rajabi MT
    Retina; 2008 Oct; 28(9):1241-6. PubMed ID: 18626423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Visual acuity and intraocular pressure after high-dose intravitreal triamcinolone acetonide in selected ocular diseases.
    Jonas JB; Schlichtenbrede F
    Eye (Lond); 2008 Jul; 22(7):869-73. PubMed ID: 17304257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe steroid-induced glaucoma following intravitreal injection of triamcinolone acetonide.
    Quiram PA; Gonzales CR; Schwartz SD
    Am J Ophthalmol; 2006 Mar; 141(3):580-2. PubMed ID: 16490518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complications of intravitreal injection of triamcinolone acetonide.
    Ozkiriş A; Erkiliç K
    Can J Ophthalmol; 2005 Feb; 40(1):63-8. PubMed ID: 15825532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequency and risk factors for intraocular pressure elevation after posterior sub-Tenon capsule triamcinolone acetonide injection.
    Iwao K; Inatani M; Kawaji T; Koga T; Mawatari Y; Tanihara H
    J Glaucoma; 2007 Mar; 16(2):251-6. PubMed ID: 17473740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraocular pressure elevation following triamcinolone acetonide administration as related to administration routes.
    Hirano Y; Ito T; Nozaki M; Yasukawa T; Sakurai E; Yoshida M; Ogura Y
    Jpn J Ophthalmol; 2009 Sep; 53(5):519-22. PubMed ID: 19847609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraocular pressure elevation after intravitreal or posterior sub-Tenon triamcinolone acetonide injection.
    Yamamoto Y; Komatsu T; Koura Y; Nishino K; Fukushima A; Ueno H
    Can J Ophthalmol; 2008 Feb; 43(1):42-7. PubMed ID: 18204501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.